Biochemical markers, liver biopsy, or magnetic resonance elastography to detect or exclude advanced fibrosis in patients with nonalcoholic fatty liver disease

Publisher： John Wiley & Sons Inc

E-ISSN： 1527-3350|62|1|324-325

ISSN： 0270-9139

Source： HEPATOLOGY, Vol.62, Iss.1, 2015-07, pp. : 324-325

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for non‐invasive diagnosis of advanced fibrosis in biopsy‐proven non‐alcoholic fatty liver disease: a prospective study

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 12, 2015-06 ,pp. : 1271-1280

John Wiley & Sons Inc

Access to resources Recommend Favorite

Magnetic resonance elastography and transient elastography as non‐invasive analyses for liver fibrosis: can they obviate the need for liver biopsy in psoriasis patients treated with methotrexate?

By  

INTERNATIONAL JOURNAL OF DERMATOLOGY, Vol. 54, Iss. 7, 2015-07 ,pp. : 752-756

John Wiley & Sons Inc

Access to resources Recommend Favorite

Value of fetuin‐A as a predictor of liver fibrosis in patients with nonalcoholic fatty liver disease

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 8, 2015-08 ,pp. : 2061-2061

John Wiley & Sons Inc

Access to resources Recommend Favorite

Utility of magnetic resonance elastography for predicting ascites in patients with chronic liver disease

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 33, Iss. 3, 2018-03 ,pp. : 733-740

John Wiley & Sons Inc

Access to resources Recommend Favorite

Novel association between serum pentraxin‐2 levels and advanced fibrosis in well‐characterised patients with non‐alcoholic fatty liver disease

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 5, 2015-09 ,pp. : 582-590

John Wiley & Sons Inc

Access to resources Recommend Favorite